SARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant) from ABBEXA LTD

Search, find, compare suppliers for SARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant) products.

Edit 
Product NameSARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant)
DescriptionSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike S1 Protein Receptor-Binding Domain (RBD) is a recombinant protein expressed in Insect cells.

The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.

The Alpha (B.1.1.7) variant was first identified in Kent, UK. It contains the N501Y mutation in the spike protein?s receptor-binding domain, which has been reported to increase binding to human ACE2. 319-541 AA. C-terminal His tag. Purity ≥ 90% (SDS-PAGE). Calculated MW: 26 kDa
Observed MW (12% reducing SDS-PAGE): ~28 kDa
Size1 mg, 10 mg, 100 mg
Concentration2.2 mg/ml
ApplicationsELISA, WB
Other NamesSevere Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, COVID-19, 2019-nCoV, 2019 novel coronavirus, COVID19, SARS-CoV-2 Spike S1 (RBD), SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, SARS-CoV-2 S1 Protein RBD (UK B.1.1.7 Variant), SARS-CoV-2 S1 Protein RBD (B.1.1.7 UKVariant), SARS-CoV-2 S1 Protein RBD N501Y Mutation, SARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant), SARS-CoV-2 S1 Protein RBD (Alpha Variant), Severe Acute Respiratory Syndrome Coronavirus 2 protein, Protein Severe Acute Respiratory Syndrome Coronavirus 2, Virus Severe Acute Respiratory Syndrome Coronavirus 2 Protein, Virus Severe Acute Respiratory Syndrome Coronavirus 2, Virus protein Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2 protein, Protein SARS-CoV-2, Virus SARS-CoV-2 Protein, Virus SARS-CoV-2, Virus protein SARS-CoV-2, COVID-19 protein, Protein COVID-19, Virus COVID-19 Protein, Virus COVID-19, Virus protein COVID-19, 2019-nCoV protein, Protein 2019-nCoV, Virus 2019-nCoV Protein, Virus 2019-nCoV, Virus protein 2019-nCoV, 2019 novel coronavirus protein, Protein 2019 novel coronavirus, Virus 2019 novel coronavirus Protein, Virus 2019 novel coronavirus, Virus protein 2019 novel coronavirus, COVID19 protein, Protein COVID19, Virus COVID19 Protein, Virus COVID19, Virus protein COVID19, SARS-CoV-2 Spike S1 (RBD) protein, Protein SARS-CoV-2 Spike S1 (RBD), Virus SARS-CoV-2 Spike S1 (RBD) Protein, Virus SARS-CoV-2 Spike S1 (RBD), Virus protein SARS-CoV-2 Spike S1 (RBD), SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein protein, Protein SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, Virus SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein Protein, Virus SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, Virus protein SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, SARS-CoV-2 S1 Protein RBD (UK B.1.1.7 Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (UK B.1.1.7 Variant), Virus SARS-CoV-2 S1 Protein RBD (UK B.1.1.7 Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (UK B.1.1.7 Variant), Virus protein SARS-CoV-2 S1 Protein RBD (UK B.1.1.7 Variant), SARS-CoV-2 S1 Protein RBD (B.1.1.7 UKVariant) protein, Protein SARS-CoV-2 S1 Protein RBD (B.1.1.7 UKVariant), Virus SARS-CoV-2 S1 Protein RBD (B.1.1.7 UKVariant) Protein, Virus SARS-CoV-2 S1 Protein RBD (B.1.1.7 UKVariant), Virus protein SARS-CoV-2 S1 Protein RBD (B.1.1.7 UKVariant), SARS-CoV-2 S1 Protein RBD N501Y Mutation protein, Protein SARS-CoV-2 S1 Protein RBD N501Y Mutation, Virus SARS-CoV-2 S1 Protein RBD N501Y Mutation Protein, Virus SARS-CoV-2 S1 Protein RBD N501Y Mutation, Virus protein SARS-CoV-2 S1 Protein RBD N501Y Mutation, SARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant), Virus SARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant), Virus protein SARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant), SARS-CoV-2 S1 Protein RBD (Alpha Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (Alpha Variant), Virus SARS-CoV-2 S1 Protein RBD (Alpha Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (Alpha Variant), Virus protein SARS-CoV-2 S1 Protein RBD (Alpha Variant)
Gene, Accession, CAS #n/a
Catalog #abx160084
Priceplease inquire
Order / More InfoSARS-CoV-2 S1 Protein RBD (Alpha B.1.1.7 Variant) from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Products

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.